Verrica Pharmaceuticals Inc
F:1NE
Verrica Pharmaceuticals Inc
F:1NE
Price:
3.5
EUR
-2.78%
Market Cap:
€148.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
V
|
Verrica Pharmaceuticals Inc
F:1NE
|
US |
|
S
|
Shanghai Industrial Holdings Ltd
XMUN:SGI
|
HK |
|
Avi Ltd
F:IZ60
|
ZA |
|
G
|
Garmin Ltd
XHAM:GEY
|
CH |
|
H
|
Hecla Mining Co
XMUN:HCL
|
US |
|
M
|
Micron Technology Inc
MIL:MU
|
US |
|
K
|
Kawasaki Kisen Kaisha Ltd
F:KLI1
|
JP |
|
A
|
ASM International NV
OTC:ASMIY
|
NL |
|
P
|
Paycom Software Inc
F:0PY
|
US |
|
United Parcel Service Inc
NYSE:UPS
|
US |
|
Brookfield Wealth Solutions Ltd
TSX:BNT
|
BM |
|
F
|
First Quantum Minerals Ltd
F:IZ1
|
CA |
Wall St Price Targets
1NE Price Targets Summary
Verrica Pharmaceuticals Inc
Verrica Pharmaceuticals Inc
Wall Street analysts forecast 1NE stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 1NE is 7.15 EUR with a low forecast of 4.29 EUR and a high forecast of 8.92 EUR.
Lowest Forecast
Price Target
4.29
EUR
23% Upside
Average Forecast
Price Target
7.15
EUR
104% Upside
Highest Forecast
Price Target
8.92
EUR
155% Upside
Verrica Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1NE's stock price target?
Price Target
7.15
EUR
7.15
EUR
According to Wall Street analysts, the average 1-year price target for 1NE is 7.15 EUR with a low forecast of 4.29 EUR and a high forecast of 8.92 EUR.
What is the Revenue forecast for Verrica Pharmaceuticals Inc?
Projected CAGR
31%
31%
The compound annual growth rate for Revenue over the next 8 years is 31%.
